Exchange: OTC·Updated 07:30 PM EST

ELOX Eloxx Pharmaceuticals Inc

$10.69
$0.04
(0.38%)
Today
Closed $10.69
$0.00
(0.00%)
After Hours
Mkt Cap$43.69M
Vol14,981.00

About ELOX

Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.
48

Neutral Sentiment

How do you feel about ELOX?

Rayvio_News_Filter
$ELOX 🏥 Eloxx Pharmaceuticals announced publication in the Journal of Clinical Investigation of Phase 2a proof-of-mechanism data showing exaluren was well tolerated and increased collagen IV abundance in all three patients with nonsense mutation Alport syndrome. Timely market event
Rayvio_News_Filter
$ELOX 🏥 Eloxx Pharmaceuticals receives FDA clearance of its IND for exaluren in nonsense-mutation ADPKD, enabling U.S. clinical sites for a Phase 2 study expected to randomize approximately 60 patients. Prioritized by relevance

Advertisement|Remove ads.